Integrative Therapy in Alcoholism

• Status: Completed
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The main aim of this project consists in the investigation of the interaction of behavior therapy and Acamprosate in the outpatient treatment of alcoholic patients in a randomized, prospective and (regarding study medication Acamprosate vs. Placebo) double blind design. A total of 371 patients has been randomly assigned immediately after detoxification to one of three different outpatient treat-ment conditions.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Heinrich-Heine University, Duesseldorf
• Collaborators: German Addiction Research Network; German Federal Ministry of Education and Research; Merck Sharp & Dohme Corp.; Psychosomatic Clinic of Bergisch Gladbach; Universität Duisburg-Essen; University of Bonn; University of Homburg
• Treatments: Acamprosate

Criteria

Inclusion Criteria:

• DSMIV criteria of alcoholism

• Age between 25 and 60

• Informed consent

Exclusion Criteria:

• Residence outside of the catchment area

• Legal reasons

• Insufficient knowledge of the German language

• Substance abuse or addiction other than alcohol or nicotine

• Pregnancy

• Serious physical illness

• Organic brain disease

• Contraindication to Acamprosate treatment